FRI331 Autoimmune Hypophysitis Secondary To Ipilimumab And Nivolumab Combination Therapy In A Patient With Advanced Renal Cell Carcinoma

Disclosure: E.Y. Ibrahim: None. I. Hulinsky: None. D. Regelmann: None. Introduction: Ipilimumab and nivolumab combination therapy is an effective immune checkpoint inhibitor regimen indicated for advanced stages of renal cell carcinoma. Autoimmune hypophysitis is a rare adverse event from this thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Eiman Y, Hulinsky, Ilja, Regelmann, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Neuroendocrinology And Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553917/
http://dx.doi.org/10.1210/jendso/bvad114.1266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553917/
http://dx.doi.org/10.1210/jendso/bvad114.1266

Ejemplares similares